A eudesmane-type sesquiterpene isolated from Pluchea odorata (L.) Cass. combats three hallmarks of cancer cells unrestricted proliferation, escape from apoptosis and early metastatic outgrowth in vitro /

Abstract Pluchea odorata is ethno pharmaceutically used to treat inflammation-associated disorders. The dichloromethane extract (DME) was tested in the carrageenan-induced rat paw oedema assay investigating its effect on inflammation that was inhibited by 37%. Also an in vitro anti-neoplastic potent...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Blaschke Michael
McKinnon Ruxandra
Huu Chi Nguyen
Holzner Silvio
Zehl Martin
Atanasov Atanas Georgiev
Schelch Karin
Krieger Sigurd
Diaz Rene
Frisch Richard
Feistel Björn
Jäger Walter
Ecker Gerhard F
Dirsch Verena M
Grusch Michael
Zupkó István
Urban Ernst
Kopp Brigitte
Krupitza Georg
Dokumentumtípus: Cikk
Megjelent: Elsevier 2015
Sorozat:MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 777
doi:10.1016/j.mrfmmm.2015.04.011

mtmt:2890601
Online Access:http://publicatio.bibl.u-szeged.hu/6938
LEADER 03121nab a2200421 i 4500
001 publ6938
005 20190311135003.0
008 160606s2015 hu o 0|| zxx d
022 |a 0027-5107 
024 7 |a 10.1016/j.mrfmmm.2015.04.011  |2 doi 
024 7 |a 2890601  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Blaschke Michael 
245 1 2 |a A eudesmane-type sesquiterpene isolated from Pluchea odorata (L.) Cass. combats three hallmarks of cancer cells  |h [elektronikus dokumentum] :  |b unrestricted proliferation, escape from apoptosis and early metastatic outgrowth in vitro /  |c  Blaschke Michael 
260 |a Elsevier  |c 2015 
300 |a 79-90 
490 0 |a MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS  |v 777 
520 3 |a Abstract Pluchea odorata is ethno pharmaceutically used to treat inflammation-associated disorders. The dichloromethane extract (DME) was tested in the carrageenan-induced rat paw oedema assay investigating its effect on inflammation that was inhibited by 37%. Also an in vitro anti-neoplastic potential was reported. However, rather limited information about the bio-activity of purified compounds and their cellular mechanisms are available. Therefore, two of the most abundant eudesmanes in P. odorata were isolated and their anti-neoplastic and anti-intravasative activities were studied. HL-60 cells were treated with P. odorata compounds and metabolic activity, cell number reduction, cell cycle progression and apoptosis induction were correlated with relevant protein expression. Tumour cell intravasation through lymph endothelial monolayers was measured and potential causal mechanisms were analysed by Western blotting. Compound PO-1 decreased the metabolic activity of HL-60 cells (IC50 = 8.9 μM after 72 h) and 10 μM PO-1 induced apoptosis, while PO-2 showed just weak anti-neoplastic activities at concentrations beyond 100 μM. PO-1 arrested the cell cycle in G1 and this correlated with induction of JunB expression. Independent of this mechanism 25 μM PO-1 decreased MCF-7 spheroid intravasation through the lymph endothelial barrier. Hence, PO-1 inhibits an early step of metastasis, impairs unrestricted proliferation and induces apoptosis at low micromolar concentrations. These results warrant further testing in vivo to challenge the potential of PO-1 as novel lead compound. 
700 0 1 |a McKinnon Ruxandra  |e aut 
700 0 1 |a Huu Chi Nguyen  |e aut 
700 0 1 |a Holzner Silvio  |e aut 
700 0 1 |a Zehl Martin  |e aut 
700 0 1 |a Atanasov Atanas Georgiev  |e aut 
700 0 1 |a Schelch Karin  |e aut 
700 0 1 |a Krieger Sigurd  |e aut 
700 0 1 |a Diaz Rene  |e aut 
700 0 1 |a Frisch Richard  |e aut 
700 0 1 |a Feistel Björn  |e aut 
700 0 1 |a Jäger Walter  |e aut 
700 0 1 |a Ecker Gerhard F  |e aut 
700 0 1 |a Dirsch Verena M  |e aut 
700 0 1 |a Grusch Michael  |e aut 
700 0 1 |a Zupkó István  |e aut 
700 0 1 |a Urban Ernst  |e aut 
700 0 1 |a Kopp Brigitte  |e aut 
700 0 1 |a Krupitza Georg  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/6938/1/138_Mutat_Res_2015.pdf  |z Dokumentum-elérés